Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small proline-rich protein 2F (SPRR2F) is a structural protein encoded by the SPRR2F gene, part of the small proline-rich (SPRR) family involved in the formation of the cornified envelope in keratinocytes by acting as a cross-linking protein that contributes to the skin’s barrier function[3]. SPRR2F is minimally expressed in healthy tissues, but its expression is rapidly and strongly upregulated in response to tissue injury, especially in the kidney, skin, uterus, esophagus, and bladder[1][3]. In the kidney, SPRR2F is a robust early response gene to acute and chronic renal injury, where it plays a protective role by helping to defend against reactive oxygen species (ROS) generated during inflammation and tissue stress, thus reducing damage and supporting tissue viability[1]. In animal models, loss of SPRR2F increases susceptibility to kidney damage and oxidative stress, while its upregulation appears protective following injuries such as ischemia-reperfusion and unilateral ureteral obstruction[1]. SPRR2F is also implicated in keratinocyte differentiation and may play a broader role in epithelial responses to tissue injury[1][3]. At present, there are no known drugs targeting SPRR2F directly, nor is it classified as a core therapeutic target such as a receptor, enzyme, or transporter. Instead, it serves primarily as a structural and protective protein with potential biomarker value in renal injury[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small proline-rich protein 2F (SPRR2F).